Skip to content

Clinical trials

Observational Lung Neoplasms trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Country / region: Sweden Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20131
20142
20151
20182
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Unknown status2
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Region Skane2
AstraZeneca1
Karolinska University Hospital1
Linkoeping University1
Lund University1
Lund University Hospital1
National Cancer Institute (NCI)1
Umeå University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms9
Cardiovascular Diseases2
Pulmonary Disease, Chronic Obstructive2
Adenocarcinoma of Lung1
Adenoma, Islet Cell1
Anus Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Squamous Cell1
Disease1
Esophageal Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.